NFP
ZBH icon

NorthLanding Financial Partners’s Zimmer Biomet ZBH Stock Holding History

NorthLanding Financial Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,195
Closed -$284K – 66
2023
Q1 		$284K Buy
2,195
+4
+0.2% +$502 0.2% 56
2022
Q4 		$279K Buy
2,191
+5
+0.2% +$580 0.2% 54
2022
Q3 		$229K Buy
+2,186
New +$240K 0.18% 59

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

NorthLanding Financial Partners's ZBH Position: Q2 2023 in Review

NorthLanding Financial Partners sold out of Zimmer Biomet (ZBH) in Q2 2023, closing a stake of 2,195 shares — an estimated $284K sold.

NorthLanding Financial Partners first reported a position in ZBH in Q3 2022 and held it in 3 quarters. The position peaked at $284K in Q1 2023. 1,031 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

  • NorthLanding Financial Partners reported no remaining Zimmer Biomet position as of Q2 2023 after selling out during the quarter.
  • NorthLanding Financial Partners sold 2,195 Zimmer Biomet shares in Q2 2023, an estimated $284K.
  • NorthLanding Financial Partners first reported a position in Zimmer Biomet in Q3 2022 and held it in 3 quarters.
  • NorthLanding Financial Partners's Zimmer Biomet position peaked at $284K in Q1 2023.
  • 1,031 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on NorthLanding Financial Partners's 13F filing for Q2 2023, filed 8 Aug 2023.